At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Relative Bioavailability of Prasugrel Orally Disintegrating Tablet Formulations and the Effect of Food on the Bioavailability of the Orally Disintegrating Tablet in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating Prasugrel ODT1 - Tablet, Prasugrel ODT2 - Tablet, and 1 other intervention for Healthy Volunteers. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the amount of drug available in the body when given to healthy participants as two different formulations with or without a meal. In addition, this study will evaluate how much of the drug gets into the blood stream and how long the body takes to get rid of it. Information about any side effects that may occur will also be collected. Each participant will receive a total of five different treatments. Each treatment is given by mouth, once a day. The treatment period lasts for five consecutive days.
Study Details
Timeline
Interventions
Administered orally as tablet.
Administered orally as tablet.
Administered orally as suspension.